Clinical trials
Other Cancer clinical trials
Below are recruiting other cancer clinical trials, each written for real people, not researchers. We’re tracking 12,892 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07647471Recruiting
Exercise program for children starting cancer treatment
This study tests whether gentle exercise during cancer treatment helps children feel better and recover faster. Researchers will guide kids through age-appropriate activities while they receive their cancer therapy.
BerlinAges 3–18 - NCT07646574Enrolling by invitation
Non-surgical treatment after immunotherapy for specific gastric cancer
This trial tests whether patients with advanced gastric cancer (a specific type called dMMR/MSI-H) can be treated without surgery after receiving immunotherapy and chemotherapy. The goal is to see if this approach can control the cancer while avoiding the risks of surgery.
Chengdu, SichuanAges 18 years+ - NCT07647289RecruitingPhase 2
Immunotherapy plus chemotherapy before bladder cancer surgery
This trial tests a combination of two drugs (eribulin and toripalimab) given before surgery to remove bladder cancer. The goal is to shrink the tumor and improve outcomes for people with advanced or high-risk bladder cancer.
Beijing, Beijing MunicipalityAges 18–80 - NCT07646639RecruitingPhase 2
Radiation, chemotherapy, and immunotherapy for advanced rectal cancer
This study tests a combination of radiation therapy, chemotherapy drugs (capecitabine and oxaliplatin), and two types of immunotherapy (a PD-1 blocker and IL-2) for locally advanced rectal cancer. The goal is to see if this combination helps shrink tumors and improve outcomes before surgery.
Nanjing, JiangsuAges 18–70 - NCT07651553Recruiting
Transanal vs. Robotic Surgery for Rectal Cancer
This trial compares two surgical approaches to remove rectal cancer while preserving bowel function. Researchers want to see which method—performed through the anus or with robotic assistance—leads to better outcomes and quality of life.
Guangzhou, GuangdongAges 18–75 - NCT07648953Recruiting
HPV Vaccine Education Videos for Cancer Survivors
This study tests short educational videos on Facebook to help young cancer survivors complete their HPV vaccine series. The HPV vaccine protects against certain cancers, and this trial aims to see if videos can help more survivors get vaccinated.
Salt Lake City, UtahAges 18–26 - NCT07653906Recruiting
Nerve block for upper abdominal cancer pain
This trial compares two nerve-block procedures to see which better relieves severe pain from cancers in the upper belly (like pancreas, stomach, liver, or bile duct). It may help if you have moderate to severe pain and are not pregnant or have certain medical conditions.
DhakaAges 18 years+ - NCT07649070RecruitingPhase 2
Virus therapy and low-dose radiation for children with aggressive brain cancer
This trial tests whether a special herpes virus (G207) combined with low-dose radiation can help children with high-grade brain tumors (gliomas). The virus is injected into the tumor to attack the cancer cells while radiation helps boost the effect.
Houston, TexasAges 3–21 - NCT07653503RecruitingPhase 1
Lymph node immunotherapy before cervical cancer surgery
This trial tests whether giving an immunotherapy drug (nivolumab) directly into lymph nodes before standard surgery can help treat cervical cancer. It is for patients who have not had prior immunotherapy treatments.
GroningenAges 18 years+ - NCT07648160Recruiting
Advanced Imaging Technology for Radiation Cancer Treatment
This study tests a new imaging camera that uses special dye to help doctors see tumors better during radiation therapy. It may help doctors target cancer more precisely while protecting healthy tissue.
Toronto, OntarioAges 18 years+ - NCT07647250Recruiting
Physical activity study for pancreatic cancer patients before surgery
This study tests if a personalized physical activity program can help pancreatic cancer patients who are receiving chemotherapy before surgery. It is designed for patients who feel weak or have early signs of frailty.
Chicago, IllinoisAges 18 years+ - NCT06240143RecruitingPhase 1/Phase 2
Intradermal immunotherapy for high-risk stage II melanoma
This trial tests if injecting two immunotherapy drugs (ipilimumab and nivolumab) just under the skin can help prevent high-risk stage II melanoma from spreading. It is for people who have recently had a thick melanoma removed and have not yet had a sentinel node biopsy.
AmsterdamAges 18 years+ - NCT06688383Recruiting
Leak after right colon cancer surgery: a study on outcomes
This study looks at how often a leak happens at the connection site after right colon cancer surgery. It includes both emergency and planned surgeries, and all types of surgical approaches. The goal is to learn more about this complication so doctors can prevent it better.
Orbassano, PiedmontAges 18 years+ - NCT07638891RecruitingPhase 1
HDM2020 for Advanced Squamous Lung Cancer
This study tests a new drug called HDM2020 in patients with advanced squamous cell lung cancer (a specific type of lung cancer) that has stopped responding to standard treatments. The drug is designed to target cancer cells that have high levels of a specific protein called FGFR2b.
Guangzhou, GuangdongAges 18–75 - NCT07644403Enrolling by invitationPhase 1/Phase 2
CAR-T Cell Therapy for Advanced Solid Tumors
This trial tests IMC001, a new type of immune cell therapy designed to fight advanced solid cancers that have stopped responding to standard treatments. The therapy uses your own immune cells engineered to recognize and attack cancer cells.
BeijingAges 18–75 - NCT07645222RecruitingPhase 1
Testing HS-20122 combined therapy for advanced lung cancer
This early-stage trial tests a new drug combination (HS-20122) for non-small cell lung cancer that has spread or cannot be surgically removed. You may qualify if your cancer has progressed despite prior treatment or you haven't received prior treatment yet.
Guangzhou, GuangdongAges 18–75 - NCT07644585Recruiting
Ultra-High Dose Rate Radiation for Recurrent Head and Neck Cancer
This trial tests a new type of radiation therapy called ConformalFLASH that delivers radiation extremely quickly to treat head and neck cancer that has come back after previous radiation. It may help patients who cannot have surgery or have declined it.
Philadelphia, PennsylvaniaAges 18 years+ - NCT07641023RecruitingPhase 1/Phase 2
CAR-NK Cell Therapy for Advanced Lung Cancer
This study tests a new type of immune cell therapy (CAR-NK cells) designed to recognize and attack lung cancer cells that have spread or stopped responding to standard treatments. The goal is to see if this approach can shrink tumors and help patients live longer.
Shenzhen, GuangdongAges 18–75 - NCT07642362Recruiting
Digital Support to Improve Quality of Life in Multiple Myeloma
This trial tests a digital app designed to help people with multiple myeloma (a blood cancer) manage their quality of life and symptoms. The study wants to see if using this app on a phone or computer can help patients feel better and stay connected to their care.
AthensAges Any age - NCT05694208Recruiting
Mobile phone education for people having gynecologic cancer surgery
This trial tests whether receiving education through your smartphone before and/or after gynecologic cancer surgery can improve your quality of life. It may help by giving you easier-to-follow information and support during recovery.
Avcılar, IstanbulAges 18 years+ - NCT06003621RecruitingPhase 2
Tiragolumab and atezolizumab for advanced solid tumors
This trial tests a combination of two immunotherapy drugs (tiragolumab and atezolizumab) for people with advanced solid tumors that have stopped responding to standard treatments or cannot be treated with available therapies. It may be an option if your tumor has certain immune-related markers.
Albury, New South WalesAges 18 years+ - NCT07645469RecruitingPhase 1
WT1-targeting T cells with azacitidine for AML
This trial tests a new type of cell therapy for people with acute myeloid leukemia (AML) that has minimal residual disease (small amounts of cancer left after treatment). The therapy uses your own immune cells, modified to target a protein called WT1 on leukemia cells, and combines it with a drug called azacitidine.
Seattle, WashingtonAges 18 years+ - NCT07638774Recruiting
Compression Gloves and Socks to Prevent Nerve Damage from UTD1 Cancer Drug
This study tests whether wearing special compression and cooling gloves and socks can help prevent nerve damage (numbness and tingling in hands and feet) that sometimes occurs in women receiving a breast cancer medication called UTD1. You would wear these gloves and socks during and after your chemotherapy treatment.
ShanghaiAges 18–75 - NCT07644091Recruiting
Caregiver Stress and Life Quality in Liver Cancer Care
This study looks at how caring for a family member with liver or bile duct cancer affects the caregiver's own stress, emotional well-being, and quality of life. Your feedback helps doctors understand and better support families facing this diagnosis.
Richardson, TexasAges 18 years+
Hear when a new Other Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for other cancer?
- Yes. Clin2 currently lists 12,892 recruiting other cancer studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a other cancer trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a other cancer trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.